Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

August 1, 2027

Study Completion Date

November 1, 2027

Conditions
Opioid Use Disorder
Interventions
DRUG

Buprenorphine

Buprenorphine in a highly effective treatment for opioid use disorder (OUD). Buprenorphine dose guidelines for OUD treatment were determined by clinical trials conducted in populations with a history of heroin use. However, fentanyl is changing the calculation of treatment, and optimal buprenorphine dosing for people who use fentanyl is unknown.

Trial Locations (1)

02912

RECRUITING

Brown University, Providence

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Brown University

OTHER

lead

Rhode Island Hospital

OTHER